AI in predicting pediatric brain cancer recurrence is revolutionizing the landscape of oncological care for children battling gliomas.Researchers at Mass General Brigham have developed an advanced AI tool that analyzes multiple brain scans over time, significantly enhancing the accuracy of recurrence risk assessment compared to traditional methods.